Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Fumi Higuchi
PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Inhibition of Mitochondria- And Endoplasmic Reticulum Stress-Mediated Autophagy Augments Temozolomide-Induced Apoptosis in Glioma Cells
PLoS ONE
Multidisciplinary
Bevacizumab Monotherapy for Temozolomide-Refractory Malignant Glioma
Japanese Journal of Neurosurgery
Surgery
Neurology
Mismatch Repair Defects andO6-Methylguanine-DNA Methyltransferase Expression in Acquired Resistance to Methylating Agents in Human Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
MYC Inhibition Plus P53 Stabilization Targets Leukemic Stem Cells
Cancer Discovery
Oncology
Mismatch Repair Deficiency Is Associated With Resistance to DNA Minor Groove Alkylating Agents
British Journal of Cancer
Cancer Research
Oncology
MicroRNA-93 Promotes the Malignant Phenotypes of Human Glioma Cells and Induces Their Chemoresistance to Temozolomide
Biology Open
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24
Cancer Biotherapy and Radiopharmaceuticals
Nuclear Medicine
Radiology
Pharmacology
Cancer Research
Oncology
Imaging
Medicine
The Strategy for Enhancing Temozolomide Against Malignant Glioma
Frontiers in Oncology
Cancer Research
Oncology